CWIFX | TNBRX | CWIFX / TNBRX | |
Total Expense Ratio | 0.86 | 1.35 | 64% |
Annual Report Gross Expense Ratio | 0.86 | 1.62 | 53% |
Fund Existence | 23 years | 11 years | - |
Gain YTD | 20.108 | 10.908 | 184% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 141B | 260M | 54,231% |
Annual Yield % from dividends | 1.53 | 0.64 | 238% |
Returns for 1 year | 10.94 | 5.04 | 217% |
Returns for 3 years | 68.69 | 54.97 | 125% |
Returns for 5 years | 55.22 | 49.81 | 111% |
Returns for 10 years | 103.66 | 118.01 | 88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 161.38 | 1.46 | +0.91% |
Franklin Biotechnology Discovery A | |||
ARDEX | 6.15 | 0.02 | +0.33% |
AMG River Road Dividend All Cap Value N | |||
MRSIX | 27.74 | -0.02 | -0.07% |
MFS Research International I | |||
CIVGX | 20.27 | -0.04 | -0.20% |
American Funds International Vntg 529-F2 | |||
OEQAX | 10.06 | -0.10 | -0.98% |
Oaktree Emerging Markets Equity A |